(ACN) Accenture - Ratings and Ratios
Strategy, Consulting, Technology, Operations, Security
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.84% |
| Yield on Cost 5y | 3.19% |
| Yield CAGR 5y | 13.01% |
| Payout Consistency | 98.9% |
| Payout Ratio | 36.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 23.0% |
| Value at Risk 5%th | 36.3% |
| Relative Tail Risk | -4.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.95 |
| Alpha | -36.39 |
| CAGR/Max DD | 0.05 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.548 |
| Beta | 0.762 |
| Beta Downside | 0.844 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.02% |
| Mean DD | 13.51% |
| Median DD | 8.87% |
Description: ACN Accenture December 02, 2025
Accenture plc (NYSE: ACN) is a Dublin-based global professional services firm that delivers strategy, consulting, technology, and operations solutions across 10+ industry verticals, including communications, financial services, health, consumer goods, and energy. Its service portfolio spans systems integration, application management, cybersecurity, intelligent platforms, cloud, AI, data analytics, automation, and end-to-end business-process outsourcing for functions such as finance, procurement, supply chain, and HR.
In FY 2023 the company reported revenue of $61.6 billion, representing a 12% year-over-year increase, and an operating margin of roughly 15%, consistent with its historical range. The business-segment that grew fastest was Cloud & Infrastructure Services, up about 22% YoY, reflecting continued enterprise migration to public-cloud platforms.
Key macro drivers for Accenture’s outlook include: (1) sustained corporate spending on digital transformation, which the IDC estimates will grow at a 9% CAGR through 2027; (2) accelerating adoption of generative AI and large-language-model-enabled solutions, where Accenture has positioned itself as a leading implementation partner; and (3) rising demand for ESG and sustainability consulting, a service line that now contributes roughly 4% of total revenue and is expected to expand as regulatory pressure mounts.
For a deeper quantitative breakdown, the ValueRay platform offers a granular view of ACN’s valuation metrics and scenario analysis.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (7.61b TTM) > 0 and > 6% of Revenue (6% = 4.24b TTM) |
| FCFTA 0.18 (>2.0%) and ΔFCFTA 2.67pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.55% (prev 12.07%; Δ -0.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.19 (>3.0%) and CFO 12.12b > Net Income 7.61b (YES >=105%, WARN >=100%) |
| Net Debt (-1.45b) to EBITDA (12.34b) ratio: -0.12 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.41 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (626.0m) change vs 12m ago -1.36% (target <= -2.0% for YES) |
| Gross Margin 31.93% (prev 32.47%; Δ -0.54pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 113.6% (prev 110.8%; Δ 2.71pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 39.97 (EBITDA TTM 12.34b / Interest Expense TTM 263.9m) >= 6 (WARN >= 3) |
Altman Z'' 3.74
| (A) 0.13 = (Total Current Assets 28.07b - Total Current Liabilities 19.90b) / Total Assets 64.70b |
| (B) 0.34 = Retained Earnings (Balance) 22.15b / Total Assets 64.70b |
| (C) 0.17 = EBIT TTM 10.55b / Avg Total Assets 62.28b |
| (D) 0.63 = Book Value of Equity 20.55b / Total Liabilities 32.78b |
| Total Rating: 3.74 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 89.23
| 1. Piotroski 7.50pt |
| 2. FCF Yield 6.91% |
| 3. FCF Margin 16.28% |
| 4. Debt/Equity 0.27 |
| 5. Debt/Ebitda -0.12 |
| 6. ROIC - WACC (= 13.93)% |
| 7. RoE 24.98% |
| 8. Rev. Trend 86.86% |
| 9. EPS Trend 62.96% |
What is the price of ACN shares?
Over the past week, the price has changed by +0.25%, over one month by +5.40%, over three months by +10.57% and over the past year by -21.41%.
Is ACN a buy, sell or hold?
- Strong Buy: 12
- Buy: 6
- Hold: 8
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ACN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 288 | 6.1% |
| Analysts Target Price | 288 | 6.1% |
| ValueRay Target Price | 270.9 | -0.2% |
ACN Fundamental Data Overview December 28, 2025
P/E Trailing = 22.4041
P/E Forward = 19.685
P/S = 2.377
P/B = 5.3829
P/EG = 2.0934
Beta = 1.261
Revenue TTM = 70.73b USD
EBIT TTM = 10.55b USD
EBITDA TTM = 12.34b USD
Long Term Debt = 5.03b USD (from longTermDebt, last quarter)
Short Term Debt = 842.9m USD (from shortTermDebt, last quarter)
Debt = 8.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.45b USD (from netDebt column, last quarter)
Enterprise Value = 166.67b USD (168.11b + Debt 8.20b - CCE 9.65b)
Interest Coverage Ratio = 39.97 (Ebit TTM 10.55b / Interest Expense TTM 263.9m)
FCF Yield = 6.91% (FCF TTM 11.51b / Enterprise Value 166.67b)
FCF Margin = 16.28% (FCF TTM 11.51b / Revenue TTM 70.73b)
Net Margin = 10.76% (Net Income TTM 7.61b / Revenue TTM 70.73b)
Gross Margin = 31.93% ((Revenue TTM 70.73b - Cost of Revenue TTM 48.15b) / Revenue TTM)
Gross Margin QoQ = 32.91% (prev 31.89%)
Tobins Q-Ratio = 2.58 (Enterprise Value 166.67b / Total Assets 64.70b)
Interest Expense / Debt = 0.80% (Interest Expense 65.4m / Debt 8.20b)
Taxrate = 24.46% (725.8m / 2.97b)
NOPAT = 7.97b (EBIT 10.55b * (1 - 24.46%))
Current Ratio = 1.41 (Total Current Assets 28.07b / Total Current Liabilities 19.90b)
Debt / Equity = 0.27 (Debt 8.20b / totalStockholderEquity, last quarter 30.87b)
Debt / EBITDA = -0.12 (Net Debt -1.45b / EBITDA 12.34b)
Debt / FCF = -0.13 (Net Debt -1.45b / FCF TTM 11.51b)
Total Stockholder Equity = 30.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.76% (Net Income 7.61b / Total Assets 64.70b)
RoE = 24.98% (Net Income TTM 7.61b / Total Stockholder Equity 30.47b)
RoCE = 29.71% (EBIT 10.55b / Capital Employed (Equity 30.47b + L.T.Debt 5.03b))
RoIC = 22.37% (NOPAT 7.97b / Invested Capital 35.62b)
WACC = 8.44% (E(168.11b)/V(176.32b) * Re(8.82%) + D(8.20b)/V(176.32b) * Rd(0.80%) * (1-Tc(0.24)))
Discount Rate = 8.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.89%
[DCF Debug] Terminal Value 76.38% ; FCFE base≈10.53b ; Y1≈11.14b ; Y5≈13.23b
Fair Price DCF = 326.4 (DCF Value 200.87b / Shares Outstanding 615.4m; 5y FCF grow 6.37% → 3.0% )
EPS Correlation: 62.96 | EPS CAGR: 12.42% | SUE: 2.85 | # QB: 1
Revenue Correlation: 86.86 | Revenue CAGR: 6.03% | SUE: 0.92 | # QB: 3
EPS next Quarter (2026-02-28): EPS=2.86 | Chg30d=-0.133 | Revisions Net=-15 | Analysts=19
EPS current Year (2026-08-31): EPS=13.85 | Chg30d=+0.007 | Revisions Net=+14 | Growth EPS=+7.1% | Growth Revenue=+5.8%
EPS next Year (2027-08-31): EPS=14.88 | Chg30d=-0.091 | Revisions Net=+3 | Growth EPS=+7.5% | Growth Revenue=+5.5%
Additional Sources for ACN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle